Trial Profile
A phase I, open label study of Edoxaban in Chinese healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation; Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism; Venous thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 03 Jan 2017 New trial record
- 27 Dec 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics